Cohance Lifesciences Limited, a amalgamated public limited company, was established on 06 July 2020 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24100MH2020PLC402958. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹3,499.94 Cr and a paid-up capital of ₹3,432.79 Cr.
Formerly known as Ai Pharmed Consultancy India Limited, Ai Pharmed Consultancy India Private Limited. It upholds a compliant status. Employing 27 professional, Its leadership includes Vinod Rao (Additional Director), Shweta Jalan (Director), Abhijit Mangalmoy Mukherjee (Director). Past directors included Shweta Jalan, Umesh Kanji Makwana, Abhijit Mangalmoy Mukherjee. It holds ₹563.47 Cr open charges and ₹299.77 Cr settled loans. Its latest AGM occurred on 12 July 2024, with the balance sheet filed on 31 March 2024. It is based at 215 Atrium, C Wing, 8Th Floor, 819-821, Andheri Kurla Road, Chakala, Andheri East, Mumbai, Maharashtra, 400093.
U24100MH2020PLC402958
402958
06 July 2020
₹3,499.94 Cr
₹3,432.79 Cr
Roc Mumbai
Unlisted
Amalgamated
Explore comprehensive insights into Cohance Lifesciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vinod Rao | Additional Director | 17 Dec 2024 | Current |
| Shweta Jalan | Director | 12 Jul 2021 | Current |
| Abhijit Mangalmoy Mukherjee | Director | 27 Oct 2022 | Current |
| Venkatanaga Kali Vetukuri Vara Prasada Raju | Managing Director | 27 Oct 2022 | Current |
| Pankaj Patwari | Director | 20 Jul 2020 | Current |
| Bhaskar Vemban Iyer | Director | 27 Oct 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Dec 2021 | Past |
| Pramod Abcsdd | Director | 21 Jul 2020 | Past |
| Pramod Abcsdd | Additional Director | 05 Feb 2023 | Past |
| Pramod Abcsdd | Director | 31 Oct 2022 | Past |
| Pramod Abcsdd | Director | 31 Oct 2022 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cohance Lifesciences Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2024, Cohance Lifesciences had a promoter holding of 99.97% and a public holding of 0.03%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹5,634,727,276.00
₹2,997,727,276.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Jul 2023 | Hdfc Bank Limited | ₹55.00 Cr | Satisfied |
| 07 Jul 2023 | Others | ₹55.00 Cr | Satisfied |
| 31 Oct 2022 | Hdfc Bank Limited | ₹38.67 Cr | Satisfied |
| 15 Sep 2022 | State Bank Of India | ₹80.00 Cr | Satisfied |
| 23 Sep 2019 | Others | ₹18.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Cohance Lifesciences has a workforce of 27 employees as of Sep 23, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Cohance Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cohance Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge registered on 23 Sep 2019 via Charge ID 100294950 with Others was fully satisfied on 18 Dec 2024. was completed.
Progress on Vinod Rao was appointed as a Additional Director was appointed as a Additional Director on 17 Dec 2024 & has been associated with this company since 1 year 1 month . was documented.
Sudarsan Maddi was appointed as a CFO was appointed as a CFO on 22 Aug 2024 & has been associated with this company since 1 year 4 months . was recorded as a recent event.
Cohance Lifesciences Limited last Annual general meeting of members was held on 12 Jul 2024 as per latest MCA records. was recorded as a recent event.
A charge registered on 07 Jul 2023 via Charge ID 100742978 with Others was fully satisfied on 29 Apr 2024. was recorded as a recent event.
Cohance Lifesciences Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Suven Pharmaceuticals on Thursday said it will merge with contract development and manufacturing organisation platform Cohance Lifesciences. The entities annou....
The CIN of Cohance Lifesciences Limited is U24100MH2020PLC402958.
Cohance Lifesciences Limited is headquartered at 215 Atrium, C Wing, 8Th Floor, 819-821, Andheri Kurla Road, Chakala, Andheri East, Mumbai, Maharashtra, 400093.
Cohance Lifesciences Limited was incorporated on 06 July 2020.
The current directors of Cohance Lifesciences Limited are
The primary industry of Cohance Lifesciences Limited is Manufacturing.
Cohance Lifesciences Limited is unlisted.
The authorized capital of Cohance Lifesciences Limited is ₹3,499.94 Cr, and the paid-up capital is ₹3,432.79 Cr.
The compliance status of Cohance Lifesciences Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX